Tuesday, September 1, 2020

FDA expands use of remdesivir as COVID-19 treatment

The Hill
The Food and Drug Administration (FDA) late Friday evening announced it was allowing the drug remdesivir to be used for all patients hospitalized with the coronavirus. The agency said in a press release that it would expand the emergency use authorization of the drug to allow it to be used for “treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19, irrespective of their severity of disease.”

No comments:

Post a Comment